Journal of Affective Disorders
Volume 122, Issue 1 , Pages 10-13 , April 2010

Women's Reproductive Related Disorders (RRDs)

  • Uriel Halbreich

      Affiliations

    • Corresponding Author InformationTel.: +1 716 829 3808, +1 716 316 4440; fax: +1 716 829 3812.

Received 3 January 2009 ,Accepted 12 May 2009.

References 

  1. In:  Alexander JL,  Kotz K,  Dennerstein L editor. Diagnosis and clinical management of the perimenopause in the symptomatic woman. Alexander Foundation for women's Health Guidelines. 2005;May; www.ajwh.org
  2. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington DC: American Psychiatric Association Publishing; 1994;
  3. Angst J, Gamma A, Gastpar M, Lepine JP, Mendlewicz J, Tylee A. Gender differences in depression epidemiological finding from the European DEPRES I and II studies. European Archives of Psychiatry and Clinical Neuroscience. 2002;252(5):201–209
  4. Barnet B, Joffe A, Duggan AK, Wilson MD, Repke JT. Depressive symptoms, stress, and social support in pregnant and postpartum adolescents. Archives of Pediatrics & Adolescent Medicine. 1996;150:64–69
  5. Brockington I. Motherhood and Mental Health. Oxford, UK: Oxford University Press; 1996;
  6. Feld J, Halbreich U, Karkun S. The association of perimenopausal mood disorders with other reproductive related disorders. CNS spectrum. 2005;10:461–470
  7. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347:930–933
  8. Halbreich U. Hormones and depression-conceptual transitions. In:  Halbreich U editors. Hormones and Depression. New York: Raven Press; 1987;p. 1–20
  9. Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology. 2003;28(Suppl 3):55–99
  10. Halbreich, U. (Ed), 2003b. Anxiety disorders in women, Depression and Anxiety 17 (3), 107–189.
  11. Halbreich, U., (Ed), 2003c. New advances in PMS/PMDD, PsychoNeuroEndocrinology 28 (S3), 1–99.
  12. Halbreich U. Postpartum disorders: multiple interacting underlying mechanisms and risk factors. Journal of Affective Disorders. 2005;88:1–7
  13. Halbreich U. Major depression is not a diagnosis, it is a departure point to differential diagnosis—clinical and hormonal considerations (A commentary and elaboration on Antonejevic's paper). Psychoneuroendocrinology. 2006;31(1):16–22
  14. Halbreich U. Selective serotonin reuptake inhibitors (SSRIs) and initial oral contraceptives (OCs) for treatment of PMDD—effective but not enough. CNS spectrums. 2008;13(7):566–572
  15. Halbreich U, Endicott J. The relationship between dysphoric premenstrual changes to depressive disorder. Acta Psychiatrica Scandinavica. 1985;71:331–338
  16. Halbreich, U., Kornstein, S.G., (Eds), 2004a. Mental symptoms and disorders during pregnancy, CNS spectrums 9 (3), 176–231.
  17. Halbreich, U., Kornstein, S.G., (Eds), 2004b. Postpartum disorders, Primary Psychiatry 11 (3), 28–56.
  18. Halbreich, U., Kornstein, S.G., (Eds), 2005. The transition from reproductive age to menopause: Implications for mental health. CNS spectr. 10 (6), 447–497.
  19. Halbreich U, Karkun S. Cross cultural and social diversity of prevalence of post partum depression and depressive symptoms. Journal of Affective Disorders. 2006;91:97–111
  20. Halbreich U, Kahn L. Atypical depression, somatic depression and anxious depression in women: are they gender preferred phenotypes?. Journal of Affective Disorders. 2007;102:245–258
  21. Halbreich U, Endicott J, Schacht S, Nee J. The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form. Acta Psychiatrica Scandinavica. 1982;65:46–65
  22. Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology. 2003;28(S3):1–23
  23. Halbreich U, Alarcon R, Calil H. Culturally-sensitive complaints of depressions and anxieties in women. Journal of Affective Disorders. 2007;102:159–176
  24. Hobfoll SE, Ritter C, Lavin J, Hulsizer MR, Cameron RP. Depression prevalence and incidence among inner-city pregnant and postpartum women. Journal of Consulting and Clinical Psychology. 1995;63(3):445–453
  25. Kantero RL, Windholm O. Correlations of menstrual traits between adolescent girls and their mothers. Acta Obstetricia et Gynecologica Scandinavica. 1971;30–36(Suppl 14)
  26. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry. 1994;51(1):8–19
  27. Kornstein, S.G., Halbreich, U. (Eds), 2003. Psychiatric issues in women, Primary Psychiatry 10 (12), 30–65.
  28. Kornstein, S.G., Halbreich, U. (Eds), 2004. PMS and PMDD, Primary Psychiatry 11 (12), 26–57.
  29. Landen M, Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorder. Depression and Anxiety. 2003;17:122–129
  30. Schmidt PJ, Nieman L, Danaceau M,A, et al. Estrogen replacement in perimenopause related depression: a preliminary report. American Journal of Obstetrics and Gynecology. 2000;183:414–420
  31. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal Women. A double-blind, randomized, placebo-controlled trial. Archives of General Psychiatry. 2001;58:529–534
  32. Smith RN, Studd JW, Zamblera D, Holland E. A randomized comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome. British Journal of Obstetrics and Gynaecology. 1995;102:475–484
  33. Steiner M, Steinberg S, Stewart D. For the Canadian Fluoxetine premenstrual dysphoria collaborative study group. Fluoxetine in the treatment of premenstrual dysphoria. New England Journal of Medicine. 1995;332(23):1529–1534
  34. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276(4):293–299
  35. Wittchen HU, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychological Medicine January. 2002;32(1):119–132
  36. World Health Organization (WHO) . The World Health Report: Mental Health: New Understanding, New hopes. Geneva, Switzerland: WHO; 2001;2001
  37. Zayas LH, Cunningham M, McKee MD, Jankowski KR. Depression and negative life events among pregnant African-American and Hispanic women. Womens Health Issues. 2002;12(1):16–22

PII: S0165-0327(09)00217-1

doi: 10.1016/j.jad.2009.05.018

Journal of Affective Disorders
Volume 122, Issue 1 , Pages 10-13 , April 2010

Article Tools